HUMANA INCHUM

Market cap
$31.3B
P/E ratio
Dec 31,
2010
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net income----------2,9342,8022,4841,214
Gain on sale of Gentiva Hospice----270---786---237--
(Gain) loss on investment securities, net---------838-130-205-5424
Equity in net losses-------11147465-4-63-94
Stock-based compensation63829298109115157137163181180216175207
Depreciation--------505528640749850908
Amortization----93777590--73966760
Tangible Asset Impairment Charges-----------248206237
Impairment of indefinite-lived intangible assets------------55200
Deferred income taxes-------------167-192
Receivables46-326251264180158-406200328528054337669
Other assets-81253330952872-426582484-1185814914631,318-1,003
Benefits payable247-41109582501-4131052521,1422,139104975915199
Other liabilities722300313413-129937641-67647159917644841-373
Unearned revenues--------95-3671-6532-20-6
Other, net--------90494070113108
Net cash provided by operating activities2,2421,9231,7161,6188681,9364,0512,1735,2845,6392,2624,5873,9812,966
Proceeds from sale of Gentiva Hospice, net-----------2,701--
Acquisitions, net of cash and cash equivalents acquired8321,2351871838731354-7094,18733723389
Purchases of property and equipment2224104415285235275266127369641,3161,1201,004575
Proceeds from sale of property and equipment0-4-1-2-----2107
Changes in securities lending collateral receivable-------------418
Purchases of investment securities4,5893,2213,2612,8836,7396,5666,2654,6876,3619,1257,1976,0497,5528,185
Proceeds from maturities of investment securities1,7501,4971,0778851,0651,4261,1119721,7334,9862,5971,3651,2922,982
Proceeds from sales of investment securities2,0121,4041,5922,4095,4934,3122,7683,4944,0862,7473,5472,4343,7953,376
Other-------------50
Net cash used in investing activities-1,811-1,965-1,182-63320-1,362-2,941-3,087-1,278-3,065-6,556-1,006-3,492-2,952
(Payments) receipts from contract deposits, net----------306-1,993-8281,933
Proceeds from issuance of senior notes, net-990-1,733--1,779-9871,0882,9841,9822,5442,232
Repayment of senior notes---------400-1,0001,8321,107
Proceeds from (Repayments of) Commercial Paper------2-153485-360-352-376211-907
Proceeds from Short-Term Debt-------1,000----100-
Repayment of short-term borrowings-------350----100-
Repayment of term loan------------500-
Debt issue costs8---------31677
Common stock repurchases1095185318723851043,3651,0901,0701,820792,0961,573817
Dividends paid-165168172172177220265291323354392431431
Changes in securities lending payable-------------418
Changes in rebate factor payable-------------123
Change in book overdraft-1879-69-33-89-713054956-285550
Other, net-----------9-151-108
Net cash used in financing activities-371-29-702-758-552732-945-785-2,295-1,9553,015-1,914-856-2,487
(Decrease) increase in cash and cash equivalents--------1,711619-1,2791,667-367-2,473
Interest payments-------195212258285354394584
Income Taxes Paid, Net7857457341,0301,1799161,4986315181,132227758997570
Fair Value of Assets Acquired1,0431,5351961838731392288199,804460462124
Less: Fair value of liabilities assumed-3009----38281103,2357023435
Less: Noncontrolling interests acquired----------2253-5-
Payments to Acquire Businesses, Net of Cash Acquired8321,2351871838731354-7094,18733723389